Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease
Clinical trial NCT05094011 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05094011
- Sponsor
- Taiwan Mitochondrion Applied Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-09-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.